ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 939

$1.39M Total Retail Price of All Prescriptions

Rank: 15 out of 939

723 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 723 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 723 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 23,869 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 1,413 1,256 1 7
POTASSIUM CHLORIDE 1,148 967 2 9
SIMVASTATIN 1,024 819 3 2
LISINOPRIL 946 785 4 3
HYDROCODONE-ACETAMINOPHEN 798 646 S3 5 1
WARFARIN SODIUM 752 643 6 17
OMEPRAZOLE 727 632 7 5
LEVOTHYROXINE SODIUM 694 616 8 4
AMLODIPINE BESYLATE 682 611 9 6
CITALOPRAM HBR 506 424 10 15
LOSARTAN POTASSIUM 446 417 11 29
ATENOLOL 437 372 12 19
METOPROLOL TARTRATE 415 268 13 10
DONEPEZIL HCL 393 378 14 30
HYDROCHLOROTHIAZIDE 378 317 15 12
RANITIDINE HCL 346 255 16 35
NAMENDA 345 326 17 49
CARVEDILOL 335 327 18 25
GABAPENTIN 335 246 18 11
NEXIUM 269 218 20 18
TRIAMCINOLONE ACETONIDE 258 203 21 150
CLONIDINE HCL 257 233 22 39
SPIRONOLACTONE 254 233 23 71
SERTRALINE HCL 245 201 24 24
ATORVASTATIN CALCIUM 238 203 25 22
CLOPIDOGREL 234 207 26 28
CYMBALTA 229 179 27 44
METFORMIN HCL 227 147 28 8
ALLOPURINOL 217 209 29 31
DIGOXIN 210 208 30 45
TAMSULOSIN HCL 201 176 31 27
MIRTAZAPINE 199 183 32 56
GLIPIZIDE 195 187 33 52
METOLAZONE 193 167 34 181
PLAVIX 186 166 35 48
CRESTOR 176 137 36 34
LANTUS 170 121 37 59
QUETIAPINE FUMARATE 166 148 38 69
TRAMADOL HCL 166 125 38 16
FLUTICASONE PROPIONATE 163 96 40 43
LOVASTATIN 160 104 41 46
AMITRIPTYLINE HCL 160 136 R 41 38
RISPERIDONE 150 96 43 82
PROAIR HFA 147 81 44 41
CELEBREX 146 122 45 106
ALENDRONATE SODIUM 144 109 46 40
POLYETHYLENE GLYCOL 3350 144 128 46 57
INSULIN SYRINGE 139 97 48 97
MEGESTROL ACETATE 138 108 R 49 136
DILTIAZEM 24HR CD 137 136 50 126
ESCITALOPRAM OXALATE 133 102 51 61
ROPINIROLE HCL 130 92 52 78
ADVAIR DISKUS 130 74 52 60
ZETIA 124 101 54 103
LIPITOR 121 110 55 127
DIOVAN 121 93 55 50
MELOXICAM 119 111 57 14
DETROL LA 118 95 58 155
PREDNISONE 118 111 58 42
NOVOLOG 116 59 60 145
AZITHROMYCIN 116 89 60 32
KLOR-CON M20 116 103 60 90
CIPROFLOXACIN HCL 114 96 63 54
HYDRALAZINE HCL 113 99 64 130
ISOSORBIDE MONONITRATE ER 111 89 65 53
FAMOTIDINE 109 67 66 62
METOPROLOL SUCCINATE 108 104 67 21
ZOLPIDEM TARTRATE 108 82 67 20
PROMETHAZINE HCL 106 71 R 69 68
DIVALPROEX SODIUM 106 71 69 95
MONTELUKAST SODIUM 106 72 69 172
FENTANYL 102 102 S2 72 104
SINGULAIR 100 76 73 101
BUSPIRONE HCL 97 65 74 123
KLOR-CON 10 96 82 75 158
VERAPAMIL ER 94 67 76 85
TRAZODONE HCL 91 38 77 26
FLUOXETINE HCL 91 37 77 47
JANTOVEN 91 83 77 260
DILTIAZEM ER 90 87 80 94
PREMARIN 86 84 R 81 111
PRAVASTATIN SODIUM 86 81 81 13
LYRICA 84 56 83 63
NAPROXEN 83 44 84 72
VENLAFAXINE HCL ER 83 33 84 121
LEVEMIR 83 70 84 168
CHLORTHALIDONE 83 83 84 165
VENLAFAXINE HCL 82 82 88 159
ENALAPRIL MALEATE 80 68 89 65
PANTOPRAZOLE SODIUM 76 64 90 66
KLOR-CON M10 76 68 90 163
LEVETIRACETAM 76 21 90 170
SEROQUEL 73 71 93 139
AMIODARONE HCL 73 64 93 160
NOVOLIN R 72 55 95 217
GLYBURIDE 72 48 R 95 89
OXYCODONE-ACETAMINOPHEN 71 61 S2 97 138
OXYBUTYNIN CHLORIDE 67 57 98 125
JANUVIA 67 59 98 110
METOCLOPRAMIDE HCL 66 55 100 119
DOXYCYCLINE HYCLATE 66 51 100 84
ABILIFY 65 47 102 156
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 48 102 64
CEPHALEXIN 64 57 104 77
MECLIZINE HCL 62 53 105 134
PROPRANOLOL HCL 62 51 105 117
PERMETHRIN 62 46 105 337
EVISTA 60 52 108 122
GLYBURIDE-METFORMIN HCL 60 56 R 108 98
PHENYTOIN SODIUM EXTENDED 59 47 110 99
OXYBUTYNIN CHLORIDE ER 59 57 110 167
LOVAZA 59 50 110 191
NITROSTAT 57 39 113 204
NYSTATIN 56 55 114 174
ACETAMINOPHEN-CODEINE 56 39 S3 114 116
EXELON 55 55 116 151
RAMIPRIL 54 54 117 91
LEVOFLOXACIN 54 39 117 86
CYCLOBENZAPRINE HCL 53 38 R 119 36
SUCRALFATE 51 49 120 96
DILTIAZEM 24HR ER 50 36 121 253
ENDOCET 50 42 S2 121 148
CARBIDOPA-LEVODOPA 50 50 121 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.